Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$668K Sell
12,111
-640
-5% -$34.7K 0.48% 67
2025
Q4
$625K Buy
12,751
+534
+4% +$24.9K 0.46% 71
2025
Q3
$527K Buy
12,217
+365
+3% +$14.3K 0.41% 81
2025
Q2
$455K Buy
11,852
+284
+2% +$10.9K 0.39% 83
2025
Q1
$448K Buy
11,568
+418
+4% +$15.3K 0.41% 86
2024
Q4
$377K Buy
+11,150
New +$401K 0.35% 95

Other funds holding GSK

Michels Family Financial's GSK Position: Q1 2026 in Review

Michels Family Financial reduced its GSK (GSK) stake by 5% in Q1 2026, selling an estimated $34.7K and leaving 12,111 shares worth $668K. The position accounts for 0.48% of the portfolio, ranked #67.

Michels Family Financial first reported a position in GSK in Q4 2024 and has held it in 6 quarters since. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Michels Family Financial held 12,111 shares of GSK worth $668K as of Q1 2026.
  • Michels Family Financial sold 640 GSK shares in Q1 2026, an estimated $34.7K.
  • GSK made up 0.48% of Michels Family Financial's portfolio in Q1 2026, its #67 holding.
  • Michels Family Financial first reported a position in GSK in Q4 2024 and has held it in 6 quarters since.
  • 1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Michels Family Financial's 13F filing for Q1 2026, filed 24 Apr 2026.